Logo image of LSL-DB.CA

LSL Pharma Group Inc (LSL-DB.CA) Stock Price, Quote, News and Overview

TSX-V:LSL-DB - TSX Venture Exchange - - Currency: CAD

100  0 (0%)

LSL-DB.CA Quote, Performance and Key Statistics

LSL Pharma Group Inc

TSX-V:LSL-DB (5/6/2025, 7:00:00 PM)

100

0 (0%)

Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap11.55B
Shares115.53M
Float82.86M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-08 2011-03-08


LSL-DB.CA short term performance overview.The bars show the price performance of LSL-DB.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

LSL-DB.CA long term performance overview.The bars show the price performance of LSL-DB.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of LSL-DB.CA is 100 CAD.

LSL Pharma Group Inc / LSL-DB Daily stock chart

LSL-DB.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
JWEL.CA JAMIESON WELLNESS INC 21.06 1.41B
LOVE.CA CANNARA BIOTECH INC 8.87 121.60M
HILL.CA HILL STREET BEVERAGE CO INC N/A 557.60K

About LSL-DB.CA

Company Profile

LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. The company specializes in the manufacturing and marketing of natural health products (NHPs). The firm manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The firm also owns Dermolab Pharma Ltd., a contract manufacturing company that specializes in the development, manufacturing and packaging of liquid and semi-solid cosmetic, pharmaceutical and natural health products. The company serves both the Canadian and international markets. The firm's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Virage Sante Inc.

Company Info

LSL Pharma Group Inc

540, rue d'Avaugour, Office 1800

Boucherville QUEBEC CA

Employees: 114

LSL-DB Company Website

LSL-DB Investor Relations

Phone: 14506817744

LSL Pharma Group Inc / LSL-DB.CA FAQ

What is the stock price of LSL Pharma Group Inc today?

The current stock price of LSL-DB.CA is 100 CAD.


What is the ticker symbol for LSL Pharma Group Inc stock?

The exchange symbol of LSL Pharma Group Inc is LSL-DB and it is listed on the TSX Venture Exchange exchange.


On which exchange is LSL-DB.CA stock listed?

LSL-DB.CA stock is listed on the TSX Venture Exchange exchange.


What is LSL Pharma Group Inc worth?

LSL Pharma Group Inc (LSL-DB.CA) has a market capitalization of 11.55B CAD. This makes LSL-DB.CA a Large Cap stock.


How many employees does LSL Pharma Group Inc have?

LSL Pharma Group Inc (LSL-DB.CA) currently has 114 employees.


What are the support and resistance levels for LSL Pharma Group Inc (LSL-DB.CA) stock?

LSL Pharma Group Inc (LSL-DB.CA) has a support level at 99.99 and a resistance level at 100.01. Check the full technical report for a detailed analysis of LSL-DB.CA support and resistance levels.


Should I buy LSL Pharma Group Inc (LSL-DB.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LSL Pharma Group Inc (LSL-DB.CA) stock pay dividends?

LSL-DB.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of LSL Pharma Group Inc (LSL-DB.CA)?

LSL Pharma Group Inc (LSL-DB.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).


LSL-DB.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to LSL-DB.CA.


Chartmill TA Rating
Chartmill Setup Rating

LSL-DB.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to LSL-DB.CA. LSL-DB.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LSL-DB.CA Financial Highlights

Over the last trailing twelve months LSL-DB.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -17.11% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.37%
ROE -8.14%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%63.44%
Sales Q2Q%59.61%
EPS 1Y (TTM)-17.11%
Revenue 1Y (TTM)N/A

LSL-DB.CA Ownership and Analysts


Ownership
Inst OwnersN/A
Ins Owners23.12%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A